儿童猴痘的诊断、治疗和预防:专家共识声明
猴痘是人畜共患病,自1970年首例人感染以来在中西非流行,2022年5月起在96个非流行国家和地区报告社区传播,截至2022年9月14日全球病例超58,200例,中国有4例(台湾3例、香港1例)。1980年停止天花疫苗接种导致人群普遍缺乏对猴痘的免疫力。儿童易感且重症或并发症风险高。该共识由全国儿科感染、呼吸、皮肤、重症、传染病和公共卫生等专家制定,基于WHO《猴痘临床管理和感染预防控制》和中国国家卫健委《猴痘诊疗指南(2022年版)》等文件,对疑似和确诊病例的病原学、流行病学、传播、临床表现、实验室检查、诊断、鉴别诊断、治疗、出院标准、预防、处置流程和防控要点进行多学科论证。
要点
- 儿童是猴痘易感人群,且重症或并发症风险高,应作为重点防护对象。
- 截至2022年9月14日,全球96个非流行国家和地区报告猴痘病例超58,200例,存在社区传播。
- 1980年停止天花疫苗接种后,人群普遍缺乏对猴痘的交叉保护免疫力。
- 中国截至2022年9月14日报告4例猴痘病例(台湾3例、香港1例)。
- 共识旨在提高儿科医生对猴痘的认识,实现早发现、早诊断、早治疗、早处置。
适用人群与场景
- 儿童猴痘疑似和确诊病例,以及儿科医生、感染、呼吸、皮肤、重症、传染病和公共卫生等多学科医务人员。
研究设计与关键结果
- 该共识由全国儿科感染、呼吸、皮肤、重症医学、传染病和公共卫生等权威专家制定,基于WHO《猴痘临床管理和感染预防控制》、中国国家卫健委《猴痘诊疗指南(2022年版)》等相关文件,对疑似和确诊病例的病原学、流行病学、传播、临床表现、实验室检查、诊断、鉴别诊断、治疗、出院标准、预防、处置流程和防控要点进行多学科反复论证。
证据类型、等级与局限
- 证据类型:专家共识。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,应提高儿科医生对猴痘的认识,实现对儿童猴痘的早发现、早诊断、早治疗和早处置。
指南或共识出处
- WHO《猴痘临床管理和感染预防控制》
- 中国国家卫健委《猴痘诊疗指南(2022年版)》
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Monkeypox is a zoonotic disease. Since the first human monkeypox case was detected in 1970, it has been prevalent in some countries in central and western Africa. Since May 2022, monkeypox cases have been reported in more than 96 non-endemic countries and regions worldwide. As of September 14, 2022, there have been more than 58,200 human monkeypox cases, and there is community transmission. The cessation of smallpox vaccination in 1980, which had some cross-protection with monkeypox, resulted in a general lack of immunity to monkeypox, which caused global concern and vigilance. As of September 14, 2022, there are four monkeypox cases in China, including three in Taiwan province and one in Hong Kong city. Previous foreign studies have shown that children are vulnerable to monkeypox and are also at high risk for severe disease or complications. In order to improve pediatricians' understanding of monkeypox and achieve early detection, early diagnosis, early treatment, and early disposal, we have organized national authoritative experts in pediatric infection, respiratory, dermatology, critical care medicine, infectious diseases, and public health and others to formulate this expert consensus, on the basis of the latest "Clinical management and infection prevention and control for monkeypox" released by The World Health Organization, the "guidelines for diagnosis and treatment of monkeypox (version 2022)" issued by National Health Commission of the People's Republic of China and other relevant documents. During the development of this consensus, multidisciplinary experts have repeatedly demonstrated the etiology, epidemiology, transmission, clinical manifestations, laboratory examinations, diagnosis, differential diagnosis, treatment, discharge criteria, prevention, disposal process, and key points of prevention and control of suspected and confirmed cases.
参考来源
- Jiang RM, Zheng YJ, Zhou L, et al. Diagnosis, treatment, and prevention of monkeypox in children: an experts' consensus statement. World J Pediatr. 2022. PMID: 36409451. doi:10.1007/s12519-022-00624-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。